Jan 13, 2020
Amgen Announces Global Diagnostic Collaborations To Expand Molecular Testing For Patients With Non-Small Cell Lung Cancer
Nov 23, 2018
Precision Oncology Company Guardant Health AMEA announces launch of its Asia, Middle East and Africa regional headquarters in Singapore
Jul 19, 2018
New Nature Medicine Study Demonstrates Ability of The Guardant360 Assay to Predict Patient Response to Immunotherapy in Advanced Gastric Cancer Patients
Jul 12, 2018
Guardant Health Appoints Leena Das-Young to Lead Efforts to Develop Liquid Biopsy Products for Early-Stage Cancer Applications
Jul 12, 2018
Guardant Health Announces Medicare Coverage for the Guardant360 Assay in Non-Small Cell Lung Cancer
May 23, 2018
Guardant Health to Present 29 Abstracts at ASCO Advancing the Science of Liquid Biopsy Across Multiple Indications and Applications
Apr 26, 2018
Guardant Health Publishes Extensive Validation of Guardant360® Assay Comprising Largest-Published Blood-Tissue Comparison
Apr 13, 2018
Guardant Health to Present Validation Data for the GuardantOMNI(TM) assay
Mar 12, 2018
Guardant Health and National Cancer Center East Japan Announce Liquid Biopsy Arm of Lung Cancer Trial
Mar 12, 2018
Guardant Health and National Cancer Center East Japan Announce Liquid Biopsy Arm of GI Cancer Trial
Nov 16, 2017
Guardant Health Expands Support for the Development of the GuardantOMNI(TM) Assay Through New Agreement with Bristol-Myers Squibb
Nov 15, 2017
New Research Reveals Molecular Heterogeneity of Metastatic Gastroesophageal Cancer
Nov 06, 2017
Guardant Health Database Reveals Potential of Targeted Therapy Combinations to Treat Advanced Lung Cancer
Sep 26, 2017
Guardant Health Receives Investigational Device Exemption Approval from the FDA to Support Merck KGaA, Darmstadt, Germany Tepotinib Study
Jun 27, 2017
New Studies Demonstrate the Need for and Utility of Comprehensive Liquid Biopsies
Jun 22, 2017
Guardant Health Files Lanham Act Lawsuit Against Foundation Medicine Alleging False Advertising
Jun 03, 2017
Cure-One(TM) Announces Partnership with Guardant Health
Jun 03, 2017
Guardant Health announces broad, long-term alliance with Pfizer Oncology supporting multiple clinical programs with the Guardant360 assay